|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02561 VISEN PHARMA-B
Nominal 
40.020 +0.020 (+0.050%) Non-current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 |
| Property, plant, equip. & others | 130 | -53.069% | 277 | 876 | 2,352 |
| Land & other Lease Assets | 1,180 | -89.153% | 10,879 | 12,379 | 14,812 |
| Intangible Assets | 25 | -53.704% | 54 | 567 | 1,415 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 |
| Other Non-current Assets | 22,770 | -62.075% | 60,040 | 55,853 | 11,103 |
| 24,105 | -66.168% | 71,250 | 69,675 | 29,682 | |
Current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 0 | -- | 0 | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | 0 | |
| Cash & Bank Balances | 805,909 | 295.855% | 203,587 | 347,782 | 626,458 | |
| Other Current Assets | 63,345 | 233.641% | 18,986 | 26,339 | 85,132 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | |
| 869,254 | 290.548% | 222,573 | 374,121 | 711,590 | ||
Current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 239 | -71.377% | 835 | 669 | 3,740 | ||
| S-T Debt & Leases | 1,195 | -40.160% | 1,997 | 2,552 | 4,668 | ||
| Other Current Liabilities | 36,373 | -26.305% | 49,356 | 48,603 | 78,931 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | ||
| 37,807 | -27.556% | 52,188 | 51,824 | 87,339 | |||
| Net Current Assets | 831,447 | 387.981% | 170,385 | 322,297 | 624,251 | ||
| Total Assets Less Current Liabilities | 855,552 | 254.068% | 241,635 | 391,972 | 653,933 | ||
Non-current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 0 | -- | 360 | 1,097 | 1,328 | |||
| Other Non-current Liabilities | 0 | -- | 0 | 0 | 0 | |||
| 0 | -- | 360 | 1,097 | 1,328 | ||||
Capital and Reserves
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 78 | 11.429% | 70 | 70 | 70 | ||||
| Reserves | 855,474 | 254.667% | 241,205 | 390,805 | 652,535 | ||||
| Others | 0 | -- | 0 | 0 | 0 | ||||
| Shareholders' Funds | 855,552 | 254.596% | 241,275 | 390,875 | 652,605 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | ||||
| 855,552 | 254.596% | 241,275 | 390,875 | 652,605 | |||||
Commitments and Contingent Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 0 | 0 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -118,020 |
| %Change | 41.390% |
| EPS / (LPS) | RMB -1.180 |
| NBV Per Share (¥) | RMB 7.510 |